Skip to search formSkip to main contentSkip to account menu

tepoxalin

Known as: 5-(4-chlorophenyl)-N-hydroxy-1-(4-methoxyphenyl)-N-methyl-1H-pyrazole-3-propanamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
OBJECTIVE To determine whether tepoxalin alters kidney function in dogs with chronic kidney disease (CKD). ANIMALS 16 dogs with… 
2009
2009
BACKGROUND Little is known about the effect of dual cyclooxygenase (COX) and lipoxygenase inhibition on canine gastric mucosal… 
2005
2005
The objective of this study was to investigate renal function in clinically normal dogs receiving tepoxalin, a nonsteroidal… 
2000
2000
Inflammatory cells contribute to the acute and sub‐acute sequelae of radiation therapy. Tepoxalin, an inhibitor of cyclooxygenase… 
1996
1996
Inflammation is characterized by the migration of polymorphonuclear leukocytes from the vasculature into the tissue causing… 
1996
1996
This study was conducted to examine the pharmacokinetics and pharmacodynamics of tepoxalin in healthy volunteers, an… 
1996
1996
Tepoxalin [5- (4-chlorophenyl)-N-hydroxy-1-(4-methoxyphenyl)-N-methyl-1H-pyrazole -3-propanamide] is an orally active anti… 
Highly Cited
1995
Highly Cited
1995
Prostaglandin-H synthase-1, the rate-limiting enzyme in prostaglandin synthesis, has both cyclooxygenase (CO) and peroxidase (PO… 
1994
1994
Tepoxalin, a compound previously identified as a dual cyclooxygenase/lipoxygenase (CO/LO) inhibitor, is a potent inhibitor of T…